MARKET

VNDA

VNDA

Vanda Pharma
NASDAQ
5.09
+0.05
+0.99%
After Hours: 5.16 +0.07 +1.38% 19:30 09/11 EDT
OPEN
5.10
PREV CLOSE
5.04
HIGH
5.17
LOW
5.05
VOLUME
701.23K
TURNOVER
--
52 WEEK HIGH
9.94
52 WEEK LOW
4.270
MARKET CAP
307.76M
P/E (TTM)
-1.1003
1D
5D
1M
3M
1Y
5Y
1D
Corbus Pharmaceuticals Holdings Inc. Stock Sheds 7.0%, Underperforms Peers
Dow Jones · 2d ago
Corbus Pharmaceuticals Holdings Inc. Stock Slips 16.4%, Underperforms Peers
Dow Jones · 3d ago
PMV Pharma Names Herman Chief Commercial Officer Ahead Of Rezatapopt Filing
NASDAQ · 4d ago
Weekly Report: what happened at VNDA last week (0831-0904)?
Weekly Report · 5d ago
Weekly Report: what happened at VNDA last week (0824-0828)?
Weekly Report · 08/31 09:13
Corbus Pharmaceuticals Holdings Inc. Stock Rises 5.8%, Outperforms Peers
Dow Jones · 08/25 20:32
Vanda Wins First EU Orphan Designation For Imsidolimab In Generalized Pustular Psoriasis; Stock Up
NASDAQ · 08/24 12:06
Vanda awarded Orphan Designation in Europe for treatment of GPP
TipRanks · 08/24 11:10
More
About VNDA
Vanda Pharmaceuticals Inc. is a global biopharmaceutical company, which is focused on the development and commercialization of therapies to address unmet medical needs and improve the lives of patients. The Company's commercial portfolio consist of four products: Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and for the treatment of nighttime sleep disturbances in Smith-Magenis syndrome, PONVORY for the treatment of relapsing forms of multiple sclerosis (RMS) including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease , and NEREUS for the prevention of vomiting induced by motion. In addition, it has a number of drugs and/or additional indications for current products in development, including Bysanti, Imsidolimab, VTR-297, VQW-765, and others. Bysanti is the active metabolite of Fanapt.

Webull offers Vanda Pharmaceuticals Inc. stock information, including NASDAQ: VNDA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VNDA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VNDA stock methods without spending real money on the virtual paper trading platform.